Comparison between DelaPlex IPO and Qualitek Labs IPO.
DelaPlex IPO is a SME Fixed Price IPO proposed to list at NSE SME while Qualitek Labs IPO is a SME Fixed Price proposed to list at BSE SME.
| DelaPlex IPO | Qualitek Labs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Shreni Shares Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of DelaPlex IPO is up to ₹43.73 Cr whereas the issue size of the Qualitek Labs IPO is up to ₹18.65 Cr. The final issue price of DelaPlex IPO is ₹192.00 per share and of Qualitek Labs IPO is ₹100.00 per share.
| DelaPlex IPO | Qualitek Labs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹186.00 per share | |
| Issue Price (Upper) | ₹192.00 per share | |
| Issue Price (Final) | ₹192.00 per share | ₹100.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 1200 shares |
| Fresh Issue Size | 16,77,600 shares | 18,64,800 shares |
| Fresh Issue Size (Amount) | up to ₹32.21 Cr | up to ₹18.65 Cr |
| OFS Issue Size | 6,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹11.52 Cr | up to ₹0.00 Cr |
| Issue Size Total | 22,77,600 shares | 18,64,800 shares |
| Issue Size Total (Amount) | up to ₹43.73 Cr | up to ₹18.65 Cr |
DelaPlex IPO opens on Jan 25, 2024, while Qualitek Labs IPO opens on Jan 18, 2024. The closing date of DelaPlex IPO and Qualitek Labs IPO is Jan 30, 2024, and Jan 23, 2024, respectively.
| DelaPlex IPO | Qualitek Labs IPO | |
|---|---|---|
| Anchor Bid Date | Jan 24, 2024 | |
| Issue Open | Jan 25, 2024 | Jan 18, 2024 |
| Issue Close | Jan 30, 2024 | Jan 23, 2024 |
| Basis Of Allotment (Tentative) | Jan 31, 2024 | Jan 24, 2024 |
| Initiation of Refunds (Tentative) | Jan 31, 2024 | Jan 25, 2024 |
| Credit of Share (Tentative) | Feb 01, 2024 | Jan 25, 2024 |
| Listing date (Tentative) | Feb 02, 2024 | Jan 29, 2024 |
| Anchor Lockin End date 1 | Mar 01, 2024 | |
| Anchor Lockin End date 2 | Apr 30, 2024 |
DelaPlex IPO P/E ratio is 17.75, as compared to Qualitek Labs IPO P/E ratio of 18.21.
| DelaPlex IPO | Qualitek Labs IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | DelaPlex Limited Financial Information (Restated)DelaPlex Limited's revenue increased by 9.69% and profit after tax (PAT) rose by 29.23% between the financial year ending with March 31, 2023 and March 31, 2022.
| Qualitek Labs Limited Financial Information (Restated Standalone)Qualitek Labs Limited's revenue increased by 61.03% and profit after tax (PAT) rose by 161.43% between the financial year ending with March 31, 2023 and March 31, 2022.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.66 | 73.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.75 | 18.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹174.91 Cr. | ₹73.72 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 40.45% | 50.49% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 56.73% | 13.76% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.82 | ₹5.49 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 56.73% | 30.10% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the DelaPlex IPO Retail Individual Investors (RII) are offered 7,97,400 shares while in Qualitek Labs IPO retail investors are offered 7,97,400 shares. Qualified Institutional Buyers (QIB) are offered 4,55,400 shares in DelaPlex IPO and in Qualitek Labs IPO.
| DelaPlex IPO | Qualitek Labs IPO | |
|---|---|---|
| Anchor Investor Reserveration | 6,82,800 shares | |
| Market Maker Reserveration | 1,22,400 shares | 99,600 shares |
| QIB | 4,55,400 shares | |
| NII | 3,42,000 shares | 9,32,400 shares |
| RII | 7,97,400 shares | 9,32,400 shares |
| Employee | ||
| Others | ||
| Total | 22,77,600 shares | 18,64,800 shares |
DelaPlex IPO subscribed 177.80x in total, whereas Qualitek Labs IPO subscribed 58.95x.
| DelaPlex IPO | Qualitek Labs IPO | |
|---|---|---|
| QIB (times) | 90.91x | |
| NII (times) | 335.23x | 69.37x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 159.91x | 39.23x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 177.80x | 58.95x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
